Trial Profile
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 Aug 2020
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary) ; Aspirin
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2019 Status changed from active, no longer recruiting to completed.
- 03 Oct 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 03 Oct 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.